Cargando…

Dysphagia with second-generation antipsychotics: A case report and review of the literature

BACKGROUND: All antipsychotics are associated with extrapyramidal symptoms (EPS). These can present as dysphagia, esophageal dysmotility, or aspiration, all of which may not be recognized as EPS. CASE REPORT: A 62-year-old with schizophrenia, prescribed olanzapine 5 mg daily, presented agitated and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Crouse, Ericka L., Alastanos, Jennifer N., Bozymski, Kevin M., Toscano, Robert A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	College of Psychiatric & Neurologic Pharmacists 2018
Materias:	Geropsych Update
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007670/ https://www.ncbi.nlm.nih.gov/pubmed/29955499 http://dx.doi.org/10.9740/mhc.2017.03.056

Ejemplares similares

Lithium rechallenge after renal transplant
por: Beasley, Anna K., et al.
Publicado: (2018)

Evaluation of oral antipsychotic supplementation of select second-generation long-acting injectable antipsychotics in an acute-care psychiatric setting
por: Alastanos, Jennifer N., et al.
Publicado: (2019)

Paediatric population neuroimaging and the Generation R Study: the second wave
por: White, Tonya, et al.
Publicado: (2017)

Meeting report: Second Hydrogen Molecule Biomedical Symposium in Beijing, China
por: Chen, Ou-yang, et al.
Publicado: (2016)

A case report and literature review of olanzapine-associated hyperglycemia with previous history of gestational diabetes
por: Alastanos, Jennifer N., et al.
Publicado: (2022)

Strategic use of new generation antidepressants for depression: SUN(^_^) D protocol update and statistical analysis plan
por: Yonemoto, Naohiro, et al.
Publicado: (2015)

Effects of second responder programs on repeat incidents of family abuse: An updated systematic review and meta‐analysis
por: Petersen, Kevin, et al.
Publicado: (2022)

Second-Generation Antipsychotics and Extrapyramidal Adverse Effects
por: Divac, Nevena, et al.
Publicado: (2014)

Relapse Prevention in Schizophrenia: A Systematic Review and Meta-Analysis of Second-Generation Antipsychotics versus First-Generation Antipsychotics
por: Kishimoto, Taishiro, et al.
Publicado: (2011)

Second-Generation Antipsychotics and Neuroleptic Malignant Syndrome: Systematic Review and Case Report Analysis
por: Belvederi Murri, Martino, et al.
Publicado: (2015)

Neutropenia induced by several second-generation antipsychotics :A case report
por: Zarouf, H., et al.
Publicado: (2023)

Consensus on the reporting and experimental design of clinical and cognitive-behavioural neurofeedback studies (CRED-nf checklist)
por: Ros, Tomas, et al.
Publicado: (2020)

Human lacrimal gland regeneration: Perspectives and review of literature
por: Tiwari, Shubha, et al.
Publicado: (2014)

Effectiveness of second generation antipsychotics: A systematic review of randomized trials
por: Johnsen, Erik, et al.
Publicado: (2008)

Second-Generation Antipsychotic Discontinuation in First Episode Psychosis: An Updated Review
por: Miller, Brian J., et al.
Publicado: (2011)

Efficacy and Tolerability of Second-Generation Antipsychotics in Children and Adolescents With Schizophrenia
por: Kumra, Sanjiv, et al.
Publicado: (2008)

Non-invasive preimplantation genetic testing: a literature review
por: Sousa, Larissa Nogueira, et al.
Publicado: (2022)

Arterial Stiffness in Patients Taking Second-generation Antipsychotics
por: Fındıklı, Ebru, et al.
Publicado: (2016)

Antioxidant Properties of Second-Generation Antipsychotics: Focus on Microglia
por: Caruso, Giuseppe, et al.
Publicado: (2020)

Frequency of screening and SBT Technique Trial—North American Weaning Collaboration (FAST-NAWC): an update to the protocol and statistical analysis plan
por: Burns, Karen E. A., et al.
Publicado: (2023)

First-line support for assistance in breathing in children: statistical and health economic analysis plan for the FIRST-ABC trial
por: Orzechowska, Izabella, et al.
Publicado: (2020)

Update of: Marks et al., Review of Grain Fortification Legislation, Standards, and Monitoring Documents
Publicado: (2018)

First-generation vs second-generation antipsychotic drugs: The ongoing saga
por: Gupta, Sumeet
Publicado: (2010)

Baby-OSCAR: Outcome after Selective early treatment for Closure of patent ductus ARteriosus in preterm babies—a statistical analysis plan for short-term outcomes
por: Bell, Jennifer L., et al.
Publicado: (2021)

Decision aid on radioactive iodine treatment for early stage papillary thyroid cancer: update to study protocol with follow-up extension
por: Sawka, Anna M., et al.
Publicado: (2015)

Statistical analysis plan for the Prophylactic Melatonin for Delirium in Intensive Care (ProMEDIC): a randomised controlled trial
por: Wibrow, Bradley, et al.
Publicado: (2021)

Critical Review of the Use of Second-Generation Antipsychotics in Obsessive–Compulsive and Related Disorders
por: Kim, Dongmi, et al.
Publicado: (2018)

Bone graft in the treatment of nonunion of the scaphoid with necrosis of the proximal pole: a literature review()
por: Severo, Antônio Lourenço, et al.
Publicado: (2017)

E-Freeze - a randomised controlled trial evaluating the clinical and cost effectiveness of a policy of freezing embryos followed by thawed frozen embryo transfer compared with a policy of fresh embryo transfer, in women undergoing in vitro fertilisation: a statistical analysis plan
por: Bell, Jennifer L., et al.
Publicado: (2020)

A randomised controlled trial comparing palate surgery at 6 months versus 12 months of age (the TOPS trial): a statistical analysis plan
por: Conroy, Elizabeth J., et al.
Publicado: (2021)

Testing an early online intervention for the treatment of disturbed sleep during the COVID-19 pandemic in self-reported good and poor sleepers (Sleep COVID-19): study protocol for a randomised controlled trial
por: Sawdon, Olivia L., et al.
Publicado: (2021)

An internal pilot study for a randomized trial aimed at evaluating the effectiveness of iron interventions in children with non-anemic iron deficiency: the OptEC trial
por: Abdullah, Kawsari, et al.
Publicado: (2015)

Confirmatory Efficacy and Safety Trial of Magnetic Seizure Therapy for Depression (CREST-MST): protocol for identification of novel biomarkers via neurophysiology
por: Daskalakis, Zafiris J., et al.
Publicado: (2021)

Second-Generation Antipsychotic Drugs for Patients with Schizophrenia: Systematic Literature Review and Meta-analysis of Metabolic and Cardiovascular Side Effects
por: Rognoni, Carla, et al.
Publicado: (2021)

Towards a multi-arm multi-stage platform trial of disease modifying approaches in Parkinson’s disease
por: Foltynie, Tom, et al.
Publicado: (2023)

Inhibition of mouse brown adipocyte differentiation by second-generation antipsychotics
por: Oh, Jee-Eun, et al.
Publicado: (2012)

Adherence and Continuation of Treatment with First- and Second-generation Antipsychotics in Schizophrenia
por: Warikoo, Nisha, et al.
Publicado: (2014)

Second Generation Antipsychotics in the Treatment of Major Depressive Disorder: An Update
por: Wang, Sheng-Min, et al.
Publicado: (2016)

Overcoming barriers to monitoring patients taking second-generation antipsychotics
por: Peña, Anita, et al.
Publicado: (2018)

Updating the Comparative Evidence on Second‐Generation Antipsychotic Use With Schizophrenia
por: McDonagh, Marian S., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vod5s8ut33tdsiochas8h8sk0u